Resistant dermatomyositis in a rural indigenous Maya woman.

BMJ Case Reports
Katia CnopKirsten Austad

Abstract

A 28-year-old indigenous Guatemalan woman presented with 7 months of progressive weakness and numerous dermatological findings. She initially sought care within the free government-run health system and was treated with oral steroids for presumed dermatomyositis. Her symptoms progressed, including severe dysphagia, hypophonia and weakness preventing sitting. She was lost to follow-up in the public system due to financial and cultural barriers. A non-governmental organisation tailored to the needs of Maya patients provided home intravenous pulse dose methylprednisolone in the absence of first-line biologicals. With longitudinal home-based care, she achieved symptom free recovery. The rising burden of chronic non-communicable diseases highlights shortcomings in health systems evident in this case, including lack of provider capacity, limited infrastructure to test for and treat rare diseases and poor continuity of care. We provide potential solutions to help care delivery in low-resource settings adapt to the demans of chronic disease control with particular attention to social determinants of health.

References

Feb 20, 1975·The New England Journal of Medicine·A Bohan, J B Peter
Feb 13, 1975·The New England Journal of Medicine·A Bohan, J B Peter
Sep 15, 2006·The New England Journal of Medicine·Susan Okie
Sep 10, 2008·Cancer·Kristen J WellsUNKNOWN Patient Navigation Research Program
Jan 13, 2011·JAMA : the Journal of the American Medical Association·Lisa G Rider, Frederick W Miller
Jun 11, 2011·CA: a Cancer Journal for Clinicians·Electra D PaskettKristen J Wells
Apr 21, 2012·International Journal of Dermatology·Ahmad Nofal, Eman Salah El-Din
Apr 24, 2012·Acta Paediatrica·John FormanUNKNOWN International Conference for Rare Diseases and Orphan Drugs (ICORD)
Feb 6, 2013·Human Resources for Health·Seble FrehywotJames Scott
Dec 25, 2013·Handbook of Clinical Neurology·A J van der Kooi, M de Visser
Feb 7, 2014·The New England Journal of Medicine·Anne Mills
Jun 8, 2014·Biochimica Et Biophysica Acta·Yue-Bei Luo, Frank L Mastaglia
Oct 20, 2015·Bulletin of the World Health Organization·Ziad ObermeyerUNKNOWN Acute Care Development Consortium
Feb 9, 2016·Diagnostics·Ruth McNerney
May 15, 2016·International Journal for Equity in Health·Alejandro CerónWalter Flores
Jun 1, 2016·Frontiers in Neurology·Asma MalikMiguel A Guzman
Jun 21, 2016·Journal of Internal Medicine·I E LundbergM Bottai
Aug 4, 2016·Orphanet Journal of Rare Diseases·Asrul Akmal ShafieMohamed Azmi Ahmad Hassali
Mar 24, 2017·JAMA : the Journal of the American Medical Association·Michael J Young, Ethan Scheinberg
May 13, 2017·The Lancet Oncology·Jeremy SnyderAnnalise Mathers
Jun 7, 2017·Zeitschrift für Psychosomatische Medizin und Psychotherapie·David Riedl, Gerhard Schüßler
Sep 19, 2017·Healthcare : the Journal of Delivery Science and Innovation·Anita CharyPeter Rohloff
Apr 29, 2018·Seminars in Arthritis and Rheumatism·Adam SchiffenbauerFrederick W Miller

❮ Previous
Next ❯

Citations

Jul 12, 2020·Journal of Clinical Medicine·Bendix LabeitRainer Dziewas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.